Seattle Genetics, Inc. (NASDAQ:SGEN)

Big Step Forward in HER2-Positive Breast Cancer Trial

Seattle Genetics Inc. (NASDAQ: SGEN) shares jumped on Monday after the firm announced positive results from its midstage breast cancer trial. Specifically, Seattle Genetics announced positive topline results from the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Analog Devices, Blackstone, Bloom Energy, Cleveland-Cliffs, Ford, Micron, PG&E, Snap, VMWare and More

Stocks entered the first day of the fourth quarter with upside indications. This is after a volatile summer on trade war and political hot-seat issues. With the bull market now ...
Read Full Story »

Why This Successful Bladder Cancer Study May Not Be Enough

Immunomedics Inc. (NASDAQ: IMMU) shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Box, iRobot, Kimberly-Clark, Match, Oracle, Pinterest, Seattle Genetics, Texas Instruments and More

The futures traded higher Friday morning as traders and investors are wrapping up the third quarter with an eye towards earnings, which will start coming in heavy the second week ...
Read Full Story »

Top Biotech Stocks and ETFs: A Sector in Trouble or a Huge Bargain

When the stock market is hitting record highs, it's important to remember that it's really a market of stocks rather than a stock market. Not all companies are created equal. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Chipotle, CEMEX, CVS, Eli Lilly, Hewlett Packard Enterprise, IBM, Incyte, MercadoLibre, US Steel and More

Stocks were indicated to open marginally higher on Thursday, but not be enough of a line to feel like the day's direction has been set. The market has been choppy ...
Read Full Story »

Seattle Genetics Dips Despite FDA Win

Seattle Genetics Inc. (NASDAQ: SGEN) shares dipped on Monday following an update from the U.S. Food and Drug Administration (FDA). Essentially, the FDA granted Breakthrough Therapy Designation to Adcetris (brentuximab ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Analog Devices, Halliburton, Neovasc, Nike, NXP, PepsiCo, Skyworks, Whiting Petroleum and More

Stocks were indicated higher on Wednesday after a strong preliminary jobs report from ADP. While the U.S. indexes are effectively at all-time highs, many investors have seen lower upside from ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altria, ConocoPhillips, First Data, Match Group, NXP Semiconductor, Seattle Genetics and More

The futures are trading slightly higher Monday morning as investors are hoping for another solid week like the one the markets produced last week, when both the NASDAQ and the ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AK Steel, BHP Billiton, Dominion, JB Hunt, KLA-Tencor, Micron, Nucor, Oracle, Roku, US Steel and More

Stocks took a hit lower on Monday, but the major indices were looking slightly positive on Tuesday. The bull market is now over nine years old, and investors are still ...
Read Full Story »

Why Cascadian Therapeutics Shares Are Skyrocketing

Cascadian Therapeutics Inc. (NASDAQ: CASC) saw its shares absolutely skyrocket on Wednesday after it was announced that Seattle Genetics Inc. (NASDAQ: SGEN) would be acquiring the company. This is far ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Baidu, Barclays, Celgene, HPE, Intel, Kimberly-Clark, Lululemon, PayPal, Stratasys and More

Stocks have hit new highs this week and went over 23,000 for the first time. Even after a weak opening on Thursday, the market managed to come back, and shares ...
Read Full Story »

4 Biotech Stocks to Buy That May See Huge Volatility From Earnings

With the third-quarter earnings reporting season upon us, investors are checking their holdings and research to see just how things are shaping up for stocks they own. One thing is ...
Read Full Story »

Did Immunomedics Rise Too Much as Seattle Genetics Deal Terminated?

Shares of Immunomedics Inc. (NASDAQ: IMMU) saw a massive gain on Friday after the company announced the termination of its licensing deal with Seattle Genetics Inc. (NASDAQ: SGEN). It may seem ...
Read Full Story »
Good heart health

Friday’s 6 Biopharma Movers That Can’t Be Ignored

There is a very positive sentiment in the health care sector considering the new Trump administration that will be taking over in just two weeks. The health care sector was ...
Read Full Story »